Chamow & Associates hosted a free webinar titled “CDMO Selection for Bispecific Antibody Development: A Case Study Matching Capability to Need” on December 1, 2020. The webinar addressed the CDMO selection…

Selecting a CDMO for bispecific antibody development can be a challenging affair. What is the CDMO selection process and how can a company best match capability to need? Chamow & Associates is…

Dr. Steven Chamow is presenting at two virtual conferences this week, the 11th Annual World Bispecific Conference and BioProcess International Conference. Both presentations are available for viewing on the Chamow &…

Chamow & Associates is pleased to present a blog series detailing best practices for working with a contract development and manufacturing organization (CDMO). This series is intended to provide a…

Chamow & Associates is pleased to announce that BioProcess International has nominated our article, “Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A,” by Steven M. Chamow, Angela…

Chamow & Associates hosted a free webinar titled, "Developing Therapeutic Monoclonal Antibodies at Pandemic Pace" on August 25, 2020. The webinar addressed how the speed of CMC development can be…

Chamow & Associates hosted a free, two-part webinar series titled, "What Does It Take To Develop A New Drug for COVID-19?" on June 23, 2020 and June 30, 2020. These…

Chamow & Associates continues our blog series detailing best practices for working with a contract development and manufacturing organization (CDMO). This series is intended to provide a potential sponsor company…

In November of 2019, I was working for one of our clients in WuXi City, Jiangsu province when the global pandemic that became COVID-19 caught fire in Wuhan, China. Having…